16.57
前日終値:
$16.59
開ける:
$16.81
24時間の取引高:
19,279
Relative Volume:
0.02
時価総額:
$1.29B
収益:
$1.64B
当期純損益:
$-495.80M
株価収益率:
-2.5874
EPS:
-6.404
ネットキャッシュフロー:
$-45.25M
1週間 パフォーマンス:
-8.89%
1か月 パフォーマンス:
-12.10%
6か月 パフォーマンス:
+36.86%
1年 パフォーマンス:
+22.15%
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
名前
Integra Lifesciences Holdings Corp
セクター
電話
(609) 275-0500
住所
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
IART
Integra Lifesciences Holdings Corp
|
16.59 | 1.34B | 1.64B | -495.80M | -45.25M | -6.404 |
|
ABT
Abbott Laboratories
|
114.48 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
330.81 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.26 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.71 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.75 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-15 | ダウングレード | Argus | Buy → Hold |
| 2025-03-31 | アップグレード | Argus | Hold → Buy |
| 2024-12-02 | 開始されました | Morgan Stanley | Underweight |
| 2024-10-07 | アップグレード | BTIG Research | Sell → Neutral |
| 2024-07-30 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-07-30 | ダウングレード | Citigroup | Neutral → Sell |
| 2024-05-07 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-05-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | アップグレード | Citigroup | Sell → Neutral |
| 2023-12-05 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 開始されました | CL King | Buy |
| 2023-08-24 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-08 | ダウングレード | Argus | Buy → Hold |
| 2023-05-24 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-05-23 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-25 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-04-13 | ダウングレード | Truist | Buy → Hold |
| 2021-12-17 | アップグレード | JP Morgan | Underweight → Neutral |
| 2021-09-15 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 開始されました | Citigroup | Neutral |
| 2020-04-03 | 開始されました | SunTrust | Buy |
| 2020-01-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 開始されました | SunTrust | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-08-07 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | アップグレード | BTIG Research | Neutral → Buy |
| 2018-07-02 | ダウングレード | Citigroup | Buy → Neutral |
| 2018-01-05 | 再開されました | Cantor Fitzgerald | Neutral |
| 2018-01-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 開始されました | UBS | Buy |
すべてを表示
Integra Lifesciences Holdings Corp (IART) 最新ニュース
Is IART Still Attractive as Its Low Valuation Meets Execution Risks? - TradingView
Assenagon Asset Management S.A. Reduces Position in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences /US Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Paradigm Capital discloses 4.42% Integra LifeSciences (IART) stake with sole voting control - Stock Titan
Integra LifeSciences (NASDAQ:IART) Stock Price Up 6.6%Time to Buy? - MarketBeat
Quantinno Capital Management LP Reduces Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences Holdings Corporation (IART) Interactive Stock Chart - Yahoo! Finance Canada
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call - Yahoo Finance
Integra LifeSciences Holdings Corporation $IART Stock Position Trimmed by Dimensional Fund Advisors LP - MarketBeat
Glenmede Trust Co. NA Raises Stock Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Sells 96,400 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat
Why Integra LifeSciences (IART) Trimmed Its 2026 Outlook After Returning to Profitability - Yahoo Finance
integra lifesciences holdings corp Profit Warnings - RTTNews
Access Investment Management LLC Buys 268,085 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat
Vanguard Portfolio Management (IART) discloses 3.9M-share position in Integra - Stock Titan
Wells Fargo & Company Issues Positive Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - MarketBeat
IART|Integra Lifesciences Holdings Corp|Price:18.245|Chg%:+0.005 - tradingkey.com
Integra Lifesciences Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Is Integra Lifesciences Holdings Corp (IART) Undervalued After Q - GuruFocus
Integra: Q2 Earnings Snapshot - KTVB
Integra LifeSciences Reports Second Quarter 2026 Results, Updates Full-Year Revenue Guidance and Reaffirms EPS Outlook - Quiver Quantitative
Integra LifeSciences Reports Second Quarter 2026 Financial Results - Yahoo Finance Singapore
Integra LifeSciences Q2 2026 Earnings: Revenue Grows, Adjusted EPS Up, and SurgiMend Relaunch On Track - Minichart
Integra LifeSciences earnings up next: Can turnaround hold? - Investing.com
UBS initiates Integra LifeSciences stock with neutral rating - Investing.com
Ultrasonic Aspirator Market Size Projected to Reach USD 376.32 Million by 2035 | SNS Insider - GlobeNewswire Inc.
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Earns Neutral Rating from Analysts at UBS Group - MarketBeat
Integra Lifesciences Holdings Corp (IART) Institutional Confidence - TradingKey
Integra Lifesciences Holdings Corp (IART) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Integra Lifesciences Holdings Corp (IART) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Integra Lifesciences Holdings Corp - TradingKey
Integra LifeSciences (NASDAQ:IART) Reaches New 12-Month HighShould You Buy? - MarketBeat
IART|Integra Lifesciences Holdings Corp|Price:19.530|Chg%:-0.260 - TradingKey
Integra Lifesciences Holdings Corp (IART) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
Integra Lifesciences Holdings Corp (IART) Cash Flow - TradingKey
Paradigm Capital Management Inc. NY Boosts Position in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History - Yahoo! Finance Canada
Integra LifeSciences (NASDAQ:IART) Stock Price Up 6.4%Still a Buy? - MarketBeat
Kaskela Law Firm Announces Investigation of Integra LifeSciences - GuruFocus
Kaskela Law investigates Integra LifeSciences over alleged cGMP violations - scanx.trade
Integra LifeSciences (IART) to Announce Earnings on Wednesday - MarketBeat
Integra LifeSciences (NASDAQ:IART) Downgraded by Wall Street Zen to Buy - MarketBeat
How Integra LifeSciences’ Earnings Outperformance Track Record At Integra LifeSciences Holdings (IART) Has Changed Its Investment Story - Yahoo Finance
A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% D - GuruFocus
Integra LifeSciences Holdings (IART) Stock Still Looks Below Fair Value Following A 70% Five Year Fall - Yahoo Finance
Integra LifeSciences to announce Q2 2026 results on July 29 - scanx.trade
Integra LifeSciences Holdings Corporation (IART) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Integra LifeSciences to Release Results Before Market Open July 29 - Stock Titan
Integra LifeSciences stock hits 52-week high at 18.93 USD - Investing.com
Integra Lifesciences Holdings Corp (IART) 財務データ
収益
当期純利益
現金流量
EPS
Integra Lifesciences Holdings Corp (IART) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '26 |
Option Exercise |
0.00 |
1,216 |
0 |
23,152 |
| Poul Mojdeh | President & CEO |
Jan 06 '26 |
Option Exercise |
0.00 |
1,390 |
0 |
1,390 |
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
大文字化:
|
ボリューム (24 時間):